<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"FNAB":1,
"cyst":1,
"follicular adenoma":2,
"squamous metaplasia":1,
"thyroid":4,
"clear cell parathyroid lesion":1,
"water clear cell adenoma":1,
"water clear cell hyperplasia":1,
"fine-needle aspiration":2,
"malignant melanoma":1,
"thyroid cyst wall atypia":1,
"congenital hypothyroidism":1,
"dyshormonogenetic goiter":1,
"euthyroid":1,
"follicular lesion":1,
"follicular neoplasm":1,
"Cowden Disease":1,
"Cowden Syndrome":1,
"pathology":1,
"surgical management":1,
"Wnt pathway":1,
"differentiation":1,
"proliferation":2,
"signaling network":1,
"thyroid cancer":5,
"cervical lymph node metastasis":1,
"lymph node between sternocleidomastoid and sternohyoid muscles":1,
"neck dissection":1,
"papillary thyroid carcinoma":5,
"therapy":1,
"laser ablation":1,
"multinodular goiter":1,
"thyroid nodules":1,
"central compartment node dissection":1,
"chyle":1,
"lateral neck dissection":1,
"leakage":1,
"BCL-1":1,
"Ki67":1,
"brachyury":1,
"chordoma":1,
"epithelial mesenchymal transition":1,
"2D-US":1,
"3D-US":1,
"larynx":1,
"pharynx":1,
"upper airway obstructive lesions":1,
"uvula":1,
"vocal cords":1,
"Chromogranin A":1,
"Cromogranina A":1,
"Gastrinoma":1,
"Gastroenteropancreatic neuroendocrine tumors":1,
"Tumores neuroendocrinos gastroenteropancreáticos":1,
"cribriform-morular variant of papillary thyroid carcinoma":1,
"immunohistochemistry":4,
"molecular genetic analyses":1,
"poorly differentiated thyroid carcinoma":2,
"somatic APC gene mutation":1,
"magnetic resonance imaging":1,
"metastasis":3,
"neurocysticercosis":1,
"131I exposure":1,
"Three Mile Island":1,
"nuclear accident":1,
"clinical pathology":1,
"head and neck tumor":1,
"parathyroid":1,
"parathyroid carcinosarcoma":1,
"sacroma":1,
"cytology":1,
"fine-needle aspiration thyroglobulin level":1,
"lymph node metastasis":1,
"airway obstruction":1,
"bronchoscopy":1,
"interventional bronchoscopy":1,
"lung cancer":2,
"Rhabdomyosarcoma":1,
"anterior neck":1,
"head-neck":1,
"thyroid neoplasms":2,
"angiogenesis":1,
"carcinogenesis":1,
"gene expression":1,
"thyroxine":2,
"Medullary thyroid carcinoma":2,
"YAP1":1,
"miR-10a":1,
"miR-375":1,
"miR-455":1,
"microRNA":2,
"KIT":1,
"LCNEC":1,
"PDGFRA":1,
"Early glottic cancer":1,
"osteoblastoma":1,
"thyroid cartilage":1,
"voice/dysphonia":1,
"Nationwide Inpatient Sample":1,
"Volume":1,
"hypocalcemia":1,
"recurrent laryngeal nerve injury":1,
"surgery":1,
"FISH":1,
"PAX8-PPARγ":1,
"angioinvasion":1,
"outcome":2,
"prognosis":2,
"thyroid carcinoma":2,
"TTF-1":2,
"biopsy":1,
"cellblock":1,
"morphology":1,
"non–small cell lung cancer (NSCLC)":1,
"p40":1,
"p63":1,
"Cytodiagnosis":1,
"Diagnostic imaging":1,
"Fine-needle biopsy":1,
"Follicular thyroid carcinoma":2,
"Thyroid nodule":1,
"Ultrasound":2,
"interstitial photodynamic therapy (iPDT)":1,
"photodynamic therapy (PDT)":1,
"superficial photodynamic therapy (sPDT)":1,
"tracheostomy":1,
"BAY43-9006":1,
"RAF inhibitor":1,
"cetuximab":1,
"colorectal cancer therapy":1,
"combined therapy":1,
"sorafenib":2,
"sorafenib and cetuximab":1,
"18F-fluorodeoxyglucose":1,
"differentiated thyroid cancer":2,
"positron emission tomography":2,
"radioiodine therapy":1,
"Gene Amplification":1,
"Gene Regulation":1,
"Lung Lineage":1,
"NKX2-1":1,
"RET inhibitors":1,
"drug combinations":1,
"mTOR":3,
"mTOR inhibitors":1,
"oncogenic RET":1,
"VEGF":3,
"hypothyroidism":2,
"metastatic renal cell carcinoma":1,
"tyrosine kinase inhibitors":1,
"DNA damage":1,
"anaplastic thyroid carcinoma":3,
"irradiation":1,
"oncolytic virus":1,
"CTGF":1,
"connective tissue growth factor":1,
"cytokeratin-19":1,
"galectin-3":1,
"human bone marrow endothelial cell-1":1,
"tyrosine kinase-type cell surface receptor HER2":1,
"5-HIAA":1,
"5-hydroxyindoleacetic acid":1,
"70-kDa ribosomal protein S6 kinase":1,
"ACTH":1,
"AIP":1,
"AKT8 virus oncogene cellular homolog":1,
"Akt":1,
"B-cell lymphoma 2":1,
"BNCT":1,
"Bax":1,
"Bcl-2":1,
"Bcl-2-associated X":1,
"CCK":1,
"DAG":1,
"DOTA":1,
"DR4":1,
"DTPA":1,
"Dopastatin":1,
"GH":1,
"GI":1,
"GIP":1,
"GLP-1":1,
"GSK3β":1,
"Grb":1,
"Gsp":1,
"Gsα subunit protein":1,
"HGCT":1,
"IGF-1":1,
"IP3":1,
"IRS-1":1,
"JAK":1,
"JNK":1,
"Janus kinase":1,
"LAR":1,
"LDL":1,
"MAPK":1,
"Men1":1,
"NET":1,
"NHE1":1,
"NOS":1,
"Na(+)/H(+) exchanger":1,
"Neuroendocrine tumor":1,
"OGTT":1,
"Octreotide":1,
"PET":1,
"PFS":1,
"PI3K":1,
"PIP2":1,
"PKA/C":1,
"PLA/C":1,
"POMC":1,
"PRL":1,
"PTP":1,
"Pasireotide":1,
"Pituitary":1,
"RKIP":1,
"Raf":1,
"Raf kinase inhibitory protein":1,
"Ras":1,
"SH2":1,
"SH2-containing phosphatase":1,
"SHP":1,
"SPECT":1,
"SSTR":1,
"STAT3/5b":1,
"Signal transduction":1,
"Somatostatin":1,
"Somatostatin receptors":1,
"Sos":1,
"TNFR1":1,
"TPE":1,
"TSH":2,
"TTP":1,
"UFC":1,
"Zac1":1,
"adrenocorticotropic hormone":1,
"aryl hydrocarbon receptor interacting protein":1,
"boron neutron capture therapy":1,
"c-Jun NH(2)-terminal kinase":1,
"cAMP/cGMP":1,
"cholecystokinin":1,
"cyclic adenosine/guanosine monophosphate":1,
"death receptor 4":1,
"diacylglycerol":1,
"diethylenetriaminepentaacetic acid":1,
"gastrointestinal":1,
"glucagon-like peptide 1":1,
"glucose-dependent insulinotropic polypeptide":1,
"glycogen synthase kinase 3β":1,
"growth factor receptor bound protein":1,
"growth hormone":2,
"hyperglycemic clamp test":1,
"inositol 1,4,5-trisphosphate":1,
"insulin receptor substrate 1":1,
"insulin-like growth factor 1":1,
"long-acting release (or repeatable)":1,
"low-density lipoprotein":1,
"mammalian (or mechanistic) target of rapamycin":1,
"mitogen-activated protein kinase":1,
"multiple endocrine neoplasia 1":1,
"neuroendocrine tumors":1,
"nitric oxide synthase (endothelial/neuronal)":1,
"oral glucose tolerance test":1,
"p70/S6K":1,
"phosphatidylinositol 3-kinase":1,
"phosphatidylinositol 4,5-bisphosphate":1,
"phospholipase A/C":1,
"pro-opiomelanocortin":1,
"progression-free survival":1,
"prolactin":1,
"protein kinase A/C":1,
"protein tyrosine phosphatase":1,
"rapidly accelerated fibrosarcoma":1,
"rat sarcoma":1,
"rous sarcoma oncogene cellular homolog":1,
"signal transducer and activator of transcription 3/5b":1,
"single photon emission computed tomography":1,
"somatostatin receptor":1,
"son of sevenless":1,
"src":1,
"src homology 2":1,
"tetraazacyclododecanetetraacetic acid":1,
"thyroid-stimulating hormone":1,
"time to tumor progression":1,
"transient permeability enhancer":1,
"tumor necrosis factor receptor 1":1,
"urinary free cortisol":1,
"vascular endothelial growth factor":2,
"zinc finger protein that induces apoptosis and cell cycle arrest":1,
"Esophageal squamous cell carcinoma":1,
"Glycolysis":1,
"Pyruvate kinase M2":1,
"Survival":2,
"1,25(OH)(2)D(3)":1,
"1α,25-dihydroxyvitamin D(3)":1,
"1α-hydroxylase":1,
"24-hydroxylase":1,
"25-OHD(3)":1,
"25-hydroxyvitamin D(3)":1,
"ATC":1,
"CDK":1,
"CDKI":1,
"CEA":1,
"CT":1,
"CYP24A1":1,
"CYP27B1":1,
"DBP":1,
"DC":1,
"DIT":1,
"DTC":1,
"Duox":1,
"ER":1,
"FA":1,
"FGF23":1,
"FNAC":1,
"FTC":1,
"G-protein coupled receptor":1,
"GPCR":1,
"H&amp":1,
"E":1,
"H(2)0(2)":1,
"HAT":1,
"HDAC":1,
"HDACI":1,
"HPT":1,
"I-Tg":1,
"KO":1,
"MIT":1,
"MTC":1,
"NIS":1,
"PDS":1,
"PDTC":1,
"PMCA":1,
"PPI":1,
"PTC":1,
"PTH":1,
"RT-PCR":1,
"RXR":1,
"Rb":1,
"SAHA":1,
"T3":1,
"T4":1,
"TH":1,
"TKI":1,
"TPO":1,
"TRH":1,
"TSHR":1,
"Tg":1,
"US":1,
"VDR":1,
"VDRE":1,
"WT":1,
"anaplastic thyroid cancer":1,
"calcitonin":1,
"carcinoembryogenic antigen":1,
"cyclin-dependent kinase":1,
"cyclin-dependent kinase inhibitor":1,
"dendritic cells":1,
"diiodotyrosine":1,
"dual oxidase":1,
"estrogen receptor":1,
"fibroblast growth factor-23":1,
"fine needle aspiration cytology":1,
"follicular thyroid cancer":1,
"haematoxylin and eosin":1,
"histone acetyltransferase":1,
"histone deacetylase":1,
"histone deacetylase inhibitor":1,
"hydrogen peroxide":1,
"hypothalamic-pituitary-thyroid":1,
"iodinated thyroglobulin":1,
"knockout":1,
"medullary thyroid cancer":1,
"monoiodotyrosine":1,
"papillary thyroid cancer":1,
"parathormone":1,
"pendrin":1,
"plasma membrane calcium ATPase":1,
"poorly differentiated thyroid cancer":1,
"proton pump inhibitor":1,
"retinoblastoma":1,
"retinoid X receptor":1,
"reverse transcriptase–polymerase chain reaction":1,
"sodium iodide symporter":1,
"suberoylanilide hydroxamic acid":1,
"thyroglobulin":2,
"thyroid hormone":1,
"thyroid peroxidase":1,
"thyroid stimulating hormone":1,
"thyroid stimulating hormone receptor":1,
"thyrotropin releasing hormone":1,
"tri-iodothyronine":1,
"tyrosine kinase inhibitor":1,
"vitamin D binding protein":1,
"vitamin D receptor":1,
"vitamin D responsive element":1,
"wild type":1,
"Adenocarcinoma":1,
"HepPar-1 antigen":1,
"Lung":1,
"Follicular carcinoma":1,
"NAD+":1,
"SIRT3":1,
"nicotinamide phosphoribosyltransferase":1,
"papillary carcinoma":1,
"Pituitary adenoma":1,
"RAPTOR":1,
"RICTOR":1,
"invasion":1,
"staging":1,
"chemoradiation therapy":1,
"docetaxel":1,
"local control":1,
"palliative management":1,
"brachial plexus":1,
"carcinoma":1,
"papillary":1,
"plexopathy":1,
"circulating tumor cells":1,
"gastric cancer":1,
"hematogenous recurrence":1,
"peritoneal dissemination":1,
"complexity":1,
"endocrine disruption":1,
"environmental toxics":1,
"military waste":1,
"persistent organic pollutants":1,
"uncertainty":1,
"Scintillation Counting":1,
"local neoplasm recurrence":1,
"technetium Tc 99m sestamibi":1,
"thyroidectomy":1,
"Cervical lymphadenitis":1,
"Cystic shadows":1,
"Familial medullary thyroid carcinoma":1,
"Addison's disease":1,
"Adrenocortical dysfunction":1,
"Alcoholic liver disease":1,
"Amenorrhoea":1,
"Amiodarone":1,
"Androgens":1,
"Autoimmune diseases":1,
"Cirrhosis":1,
"Coagulation":1,
"Cushing's syndrome":1,
"Diabetes":1,
"Gonadal dysfunction":1,
"Gonadotropin":1,
"Hepatitis":1,
"Hyperlipidaemia":1,
"Hyperthyroidism":1,
"Hypogonadism":1,
"Infertility":1,
"Insulin resistance":1,
"Liver transplantation":1,
"Metabolic syndrome":1,
"Non-alcoholic steatohepatitis":1,
"Obesity":1,
"Oestrogens":1,
"Propylthiouracil":1,
"Sexual dysfunction":1,
"Steatosis":1,
"Thyrotoxicosis":1,
"progesterone":1,
"RECIST":1,
"differentiated thyroid carcinoma":2,
"molecular targeted therapy":1,
"Follicular variant of papillary thyroid carcinoma":1,
"Anaplastic":1,
"epidemiology":1,
"incidence":1,
"trend":1,
"NOTCH2":1,
"ovarian cancer":1,
"tumor suppressor":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2013年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
